The following provides a brief summary of medications available in Canada for acromegaly and whether they are covered by provincial pharmacare plans. While we have taken every step to keep this information up to date, it may have changed. Please consult with your medical team for the latest information and for the best treatment plan for you.
Produced by Novartis Pharmaceuticals.
Sandostatin LAR dosages available:
- 10mg
- 20mg
- 30mg
Typically one intramuscular injection every four weeks, administered by a medical professional.
Manitoba Pharmacare: covered as a general benefit; no special authorization required.
Produced by Recordati Rare Diseases.
Signifor LAR doses available:
- 40mg (initial dose)
- 60mg (max dose)
Typically one injection every 4 weeks (28 days), administered by a medical professional.
Produced by Ipsen.
Somatuline Autogel dosages available:
- 60mg
- 90mg
- 120mg
Typically one injection every four weeks, administered by a medical professional or by self-injection.
Open listing on pharmacare plan.
Care coordinated by provincial cancer agency, with shared responsibility for treatment coverage.
Produced by Pfizer.
Somavert doses:
- 10mg
- 15mg
- 20mg
- 25mg
- 30mg
Typically one self-administered subcutaneous injection per day.
Not listed, but some patients have had access through the Designated High-cost Drugs for Reduced Pharmaceutical Distribution Program (case-by-case mechanism).
Information on the various patient support programs offered for these medications is available here.